Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × OTHER × plerixafor × Clear all

Phase

Phase 2 23 Phase 1 14 Phase 1/2 9 Phase NA 2 Phase 3 2 Phase 4 1

Status

Sponsor Class

OTHER_GOV 1 OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Metformin 43 Dexamethasone 39 Saline Solution 32 Cyclophosphamide 31 Cytarabine 29 Bupivacaine 27 Sodium Chloride 25 Propofol 23 Dexmedetomidine 23 Vincristine 21 Methotrexate 21 Fluorouracil 21 Fentanyl 21 Cisplatin 19 Doxorubicin 18 Letrozole 17 Carboplatin 17 Acetaminophen 17 Morphine 16 Mercaptopurine 15 Lidocaine 15 Granulocyte Colony-Stimulating Factor 15 Bevacizumab 14 Sevoflurane 13 Ropivacaine 13 Indocyanine Green 13 Clomiphene 13 Tranexamic Acid 12 Rituximab 12 Oxaliplatin 12

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05510544 2023-03-13

Plerixafor for Poorly Mobilized Lymphoma

Peking University

Phase 4 Unknown

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡